Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · IEX Real-Time Price · USD
-0.11 (-0.77%)
Nov 27, 2023, 4:00 PM EST - Market closed

Pliant Therapeutics Revenue

Pliant Therapeutics had revenue of $3.55M in the twelve months ending September 30, 2023, down -63.53% year-over-year. In the year 2022, Pliant Therapeutics had annual revenue of $9.69M with 27.91% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
849.33M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20229.69M2.11M
Dec 31, 20217.57M-34.25M
Dec 31, 202041.82M-15.24M
Dec 31, 201957.05M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Collegium Pharmaceutical 546.64M
Phreesia 319.36M
Paragon 28 207.34M
Alpine Immune Sciences 30.80M
Editas Medicine 24.61M
Viridian Therapeutics 347.00K
Revenue Rankings